Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-07 IMVT / Immunovant, Inc. 4 Gloria Melanie A - Award D 83,671
2026-04-06 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 18.50 -6,775
2026-04-06 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 16.51 -537,754
2026-04-06 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 17.31 -44,728
2026-04-06 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.33 -19,060
2026-04-06 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 63.139 -5,900
2026-04-06 ADPT / Adaptive Biotechnologies Corporation 4 ROBINS CHAD M S - Sale D 14.41 -83,332
2026-04-06 LXEO / Lexeo Therapeutics, Inc. 4 Townsend Richard Nolan S - Sale D 5.6934 -55,000
2026-04-06 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 64.015 -4,100
2026-04-06 VIR / Vir Biotechnology, Inc. 4 De Backer Marianne S - Sale D 9.156 -72,559
2026-04-06 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 12.07 10,000
2026-04-06 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 7.27 14,722
2026-04-06 RXRX / Recursion Pharmaceuticals, Inc. 4 Taylor Ben R F - Taxes D 3.11 -48,028
2026-04-06 SANA / Sana Biotechnology, Inc. 4 Bishop Hans Edgar A - Award D 7,763
2026-04-06 GLUE / Monte Rosa Therapeutics, Inc. 4 Bowen Matthew A - Award D 4,300
2026-04-06 BCRX / BioCryst Pharmaceuticals, Inc. 4 Menon Sandeep A - Award D 205,150
2026-04-04 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory Held by James George, who has granted power of attorney to Dr. George. P - Purchase I 1.42 4,000,000
2026-04-04 MESO / Mesoblast Limited - Depositary Receipt (Common Stock) 4 George Gregory Held by James George, who has granted power of attorney to Dr. George. P - Purchase I 1.42 4,000,000
2026-04-03 TECH / Bio-Techne Corporation 4 Bohnen Shane M - Exercise D 2,259
2026-04-03 TECH / Bio-Techne Corporation 4 Bohnen Shane F - Taxes D 53.13 -740
2026-04-03 AGEN / Agenus Inc. 4 ARMEN GARO H A - Award D 3.33 4,629
2026-04-02 VCEL / Vericel Corporation 4 Hopper Jonathan Mark S - Sale D 35 -3,472
2026-04-02 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 18.23 -258,475
2026-04-02 REPL / Replimune Group, Inc. 4 Sarchi Christopher S - Sale D 8.01 -6,500
2026-04-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 64.887 -4,200
2026-04-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 64.063 -15,800
2026-04-02 KOD / Kodiak Sciences Inc. 4 BORGESON JOHN A. S - Sale D 40.88 -4,231
2026-04-02 KOD / Kodiak Sciences Inc. 4 BORGESON JOHN A. S - Sale D 40.29 -12,477
2026-04-02 IMVT / Immunovant, Inc. 4 Venker Eric S - Sale D 24.04 -12,820
2026-04-02 IMVT / Immunovant, Inc. 4 Venker Eric S - Sale D 24.60 -1,409
2026-04-02 KOD / Kodiak Sciences Inc. 4 BORGESON JOHN A. S - Sale D 41.77 -600
2026-04-02 KOD / Kodiak Sciences Inc. 4 BORGESON JOHN A. S - Sale D 39.14 -12,692
2026-04-02 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 19.06 -1,525
2026-04-02 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.60 -19,060
2026-04-02 VYGR / Voyager Therapeutics, Inc. 4 Sandrock Alfred S - Sale D 3.87 -11,511
2026-04-02 SLDB / Solid Biosciences Inc. 4 SMITH IAN F M - Exercise D 3,441
2026-04-02 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 7.27 14,722
2026-04-02 VCEL / Vericel Corporation 4 Hopper Jonathan Mark M - Exercise D 10.95 3,472
2026-04-02 MRNA / Moderna, Inc. 4 Mock James M M - Exercise D 1,453
2026-04-02 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 12.07 20,000
2026-04-02 KOD / Kodiak Sciences Inc. 4 BORGESON JOHN A. M - Exercise D 1.04 30,000
2026-04-02 MRNA / Moderna, Inc. 4 Mock James M F - Taxes D 50.03 -703
2026-04-01 BEAM / Beam Therapeutics Inc. 4 Simon Amy S - Sale D 24.58 -6,700
2026-04-01 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 85.33 -2,702
2026-04-01 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 85.89 -100
2026-04-01 APGE / Apogee Therapeutics, Inc. 4 Henderson Jane S - Sale D 85.46 -1,100
2026-04-01 TWST / Twist Bioscience Corporation 4 Starovasnik Melissa A. S - Sale D 51.00 -1,000
2026-04-01 BEAM / Beam Therapeutics Inc. 4 Bellon Christine S - Sale D 24.58 -5,956
2026-04-01 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 65.358 -19,000
2026-04-01 VIR / Vir Biotechnology, Inc. 4 SATO VICKI L S - Sale D 9.0735 -22,000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)